Skip to main content
. 2012 Mar 14;18(10):1093–1097. doi: 10.3748/wjg.v18.i10.1093

Table 2.

The HP- and CagA-positivity in patients in the different study groups

Group n HP- HP+ CagA+ CagA- Overall CagA+
Control 100 57 43 21 22 21/100
GD total 52 9 43c 36b 7 36c/52
HT total 60 32 281 25b 3 25a/60
ATDs total 112 41 712 61c 10 61c/112
a

P ≤ 0.05 vs control,

b

P ≤ 0.005,

c

P ≤ 0.0001.

1

Not significant;

2

Not calculated.